- What is Cannadorf's primary business focus?
- Cannadorf is dedicated to revolutionizing cannabis extraction for medical use, focusing on producing cannabinoids, terpenes, and flavonoids in a medically safe manner. The company aims to supply pharmaceutical companies with high-quality and sterile extracts or Active Pharmaceutical Ingredients (APIs).
- What innovative technology is Cannadorf developing?
- Cannadorf is developing a platform technology that involves cultivating sterile plant tissue in bioreactors. This approach aims to ensure the commercial production of premium plant extracts or specific APIs for pharmaceuticals, nutraceuticals, and cosmeceuticals markets.
- When was Cannadorf founded?
- Cannadorf was founded in February 2019.
- Where is Cannadorf's headquarters located?
- Cannadorf's headquarters is located in Tel Aviv-Yafo, Israel.
- What markets does Cannadorf target with its products?
- Cannadorf targets the pharmaceuticals, nutraceuticals, and cosmeceuticals markets with its high-quality and sterile plant extracts or specific APIs.
- What is Cannadorf's current funding stage?
- Cannadorf is currently in the Pre-Funding stage.
- What is Cannadorf's primary sector classification?
- Cannadorf's primary sector classification is Health Tech & Life Sciences.
